Shanghai and San Diego-based Ablaze Pharmaceuticals, a clinical-stage company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, announced…
Adagio Therapeutics announced an update on its lead SARS-CoV-2 monoclonal antibody, ADG20. ADG20 was designed to provide broad and potent neutralizing activity against SARS-CoV-2, including…
NixOx announced positive post hoc results from a subgroup of patients in the Phase 2b Mississippi clinical trial. Analysis for this subgroup of patients, who…
MEI Pharma and Kyowa Kirin announced results from the ongoing Phase 2 TIDAL study evaluating zandelisib as a single agent for follicular lymphoma (FL) patients…
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
